AmbioPharm has multiple manufacturing suites capable of producing peptide APIs (Active Pharmaceutical Ingredients) at varying scales from gram to multi-kilogram scale. We use solid phase synthesis, solution phase synthesis, and hybrid solid/solution phase synthesis to produce peptide APIs.
AmbioPharm has dedicated manufacturing lines for peptide APIs at 5 – 10kg kilogram scale scheduled for re-validation and commercial manufacturing at 150-200 kg/year scale (25-50kg batches).
AmbioPharm is one of the world’s largest custom producers. We can produce nearly any type of peptide and special modification(s) that you need. Whether it be a fatty acid acylation or a high molecular weight pegylation, we have the experience and know-how to produce your product.
From preclinical to commercial, AmbioPharm has multiple manufacturing suites capable of handling any project scale.
AmbioPharm is capable of producing biologically active peptides with target length from 5 -70 amino acid residues. Peptides with multiple disulfide bonds are a particular strength of ours.
All our processes comply with cGMP (Current Good Manufacturing Practice) regulations as required by the FDA. These regulations assure proper design, monitoring, and control of manufacturing processes and facilities. AmbioPharm’s quality process assures the identity, strength, quality, and purity of the products we manufacture.
Our Quality Control Department continuously monitors production. Using quality controls, scientifically sound design practices, processing methods, and testing procedures, we are continuously improving our processes.